Artiva Biotherapeutics, Inc.

Direct answer

Artiva Biotherapeutics, Inc. is publicly traded on NASDAQ under the ticker ARTV.

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and various forms of cancer. Its flagship therapeutic candidate, AB-101, is an innovative, ready-to-use (off-the-shelf) NK cell therapy. This treatment is being developed for a broad spectrum of conditions, including...

Can you invest in Artiva Biotherapeutics, Inc.?

Yes. Artiva Biotherapeutics, Inc. trades publicly on NASDAQ as ARTV.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Artiva Biotherapeutics, Inc.

Detailed equity research is provided by MarketSnap.